Dose escalation with proton-beam boost for low-risk prostate cancer

被引：2
|
作者：
Trabulsi, E. J.
Valicenti, R. K. [1 ]
机构：
[1] Thomas Jefferson Univ, Dept Radiat Oncol, Clin Div, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA
来源：
NATURE CLINICAL PRACTICE UROLOGY | 2006年 / 3卷 / 05期
关键词：
biochemical failure; conformal radiotherapy; dose; morbidity; prostate cancer;
D O I：
10.1038/ncpuro0477
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 257
页数：2
相关论文
共 50 条
  • [11] Active surveillance for low-risk prostate cancer
    Hadjipavlou, Marios
    Promponas, John
    Madaan, Sanjeev
    JOURNAL OF CLINICAL UROLOGY, 2015, 8 (06) : 420 - 428
  • [12] Active surveillance for low-risk prostate cancer
    Bangma, Chris H.
    Bul, Meelan
    van der Kwast, Theo H.
    Pickles, Tom
    Korfage, Ida J.
    Hoeks, Caroline M.
    Steyerberg, Ewout W.
    Jenster, Guido
    Kattan, Michael W.
    Bellardita, Lara
    Carroll, Peter R.
    Denis, Louis J.
    Parker, Chris
    Roobol, Monique J.
    Emberton, Mark
    Klotz, Laurence H.
    Rannikko, Antti
    Kakehi, Yoshiyuki
    Lane, Janet A.
    Schroder, Fritz H.
    Semjonow, Axel
    Trock, Bruce J.
    Valdagni, Riccardo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) : 295 - 302
  • [13] Active Surveillance for Low-Risk Prostate Cancer
    Klotz, Laurence
    CURRENT UROLOGY REPORTS, 2015, 16 (04) : 1 - 10
  • [14] DOSE ESCALATION IMPROVES CANCER-RELATED EVENTS AT 10 YEARS FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH HYPOFRACTIONATED HIGH-DOSE-RATE BOOST AND EXTERNAL BEAM RADIOTHERAPY
    Martinez, Alvaro A.
    Gonzalez, Jose
    Ye, Hong
    Ghilezan, Mihai
    Shetty, Sugandh
    Kernen, Kenneth
    Gustafson, Gary
    Krauss, Daniel
    Vicini, Frank
    Kestin, Larry
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (02): : 363 - 370
  • [15] TWICE-WEEKLY HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER WITH LOW-RISK NODAL INVOLVEMENT: TOXICITY AND OUTCOME FROM A DOSE ESCALATION PILOT STUDY
    Zilli, Thomas
    Jorcano, Sandra
    Rouzaud, Michel
    Dipasquale, Giovanna
    Nouet, Philippe
    Ignacio Toscas, Jose
    Casanova, Nathalie
    Wang, Hui
    Escude, Lluis
    Molla, Meritxell
    Linero, Dolors
    Weber, Damien C.
    Miralbell, Raymond
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : 382 - 389
  • [16] The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapy
    Krishnan, Vimal
    Delouya, Guila
    Bahary, Jean-Paul
    Larrivee, Sandra
    Taussky, Daniel
    BJU INTERNATIONAL, 2014, 114 (06) : 865 - 871
  • [17] Focal Therapy for Low-Risk Prostate Cancer Opinion: No
    Sugano, Dordaneh
    Abreu, Andre Luis
    Cacciamani, Giovanni E.
    Gill, Inderbir S.
    Lebastchi, Amir H.
    JOURNAL OF ENDOUROLOGY, 2021, 35 (09) : 1284 - 1287
  • [18] Utility of an initial adaptive bladder volume control with ultrasonography for proton-beam irradiation for prostate cancer
    Shigeyuki Takamatsu
    Kazutaka Yamamoto
    Mariko Kawamura
    Yoshitaka Sato
    Satoko Asahi
    Tamaki Kondou
    Yuuji Tameshige
    Yoshikazu Maeda
    Makoto Sasaki
    Tomoyasu Kumano
    Toshifumi Gabata
    Japanese Journal of Radiology, 2014, 32 : 618 - 622
  • [19] Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer
    Choe, Kevin S.
    Liauw, Stanley L.
    THESCIENTIFICWORLDJOURNAL, 2010, 10 : 1854 - 1869
  • [20] Low-risk Prostate Cancer: Identification, Management, and Outcomes
    Moschini, Marco
    Carroll, Peter R.
    Eggener, Scott E.
    Epstein, Jonathan I.
    Graefen, Markus
    Montironi, Rodolfo
    Parker, Christopher
    EUROPEAN UROLOGY, 2017, 72 (02) : 238 - 249
12345